Helen Routh, PhD

Specialty in AI Innovation

Dr. Routh is the Non-executive Chair of the Board at Ultromics, an AI-based ultrasound diagnostic support tool for coronary artery disease. She is also a Non-Executive Director at the Agfa-Gevaert Group, who develops, produces and distributes an extensive range of analog and digital imaging systems and IT solutions and at Health Innovation Manchester, a. Dr. Routh has extensive professional history in healthcare innovation, strategy and business for Royal Philips.

Practice names

2018 - Present - Chairman, Ultromics

2019 - Present - Non-Executive Director, AGFA-Gevaert Group

2019 - Present - Non-Executive Director, Health Innovation Manchester

2020 - Present - Medical Advisory Board Member, Buoy Health

2015 - 2017 - Head of Integrated Solutions, SVP Strategy & Innovation

Education and training

1983 - 1987 - PhD, Physics (Medical Ultrasound), University College Cardiff, Wales

1984 - 1985 - EE, University of Illinois at Urbana-Champaign

1980 - 1983 - BS (Physics & Music), University College Cardiff, Wales